[ANTITUMOR ACTION OF 7 MEMBERED RING COMPOUNDS. IV. PHARMACOLOGY OF 2-ISONICOTINOYLHYDRAZINO-5-NITROSOTROPONE N-OXIDE (RCH-1003)].
D000818:Animals; D000970:Antineoplastic Agents; D002286:Carcinoma, Ehrlich Tumor; D002415:Cats; D004285:Dogs; D007538:Isoniazid; D051379:Mice; D009584:Nitrogen; D009930:Organic Chemicals; D010087:Oxides; D010600:Pharmacology; D011817:Rabbits; D012106:Research
D000970:Antineoplastic Agents; D009930:Organic Chemicals; D010087:Oxides; D009584:Nitrogen; D007538:Isoniazid
ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CATS; DOGS; EXPERIMENTAL LAB STUDY; ISONIAZID; MICE; NITROGEN; PHARMACOLOGY; RABBITS